
Novogaia speeds up the discovery of fungal natural products to enable new medicines. We use metabologenomics and machine learning to map biosynthetic pathways and prioritize drug-like compounds. The platform integrates genomics, metabolomics, and computational metabolomics to profile molecules at scale. Targeting biotech and pharmaceutical researchers, Novogaia aims to expand the fungal chemistry map for therapeutic development.

Novogaia speeds up the discovery of fungal natural products to enable new medicines. We use metabologenomics and machine learning to map biosynthetic pathways and prioritize drug-like compounds. The platform integrates genomics, metabolomics, and computational metabolomics to profile molecules at scale. Targeting biotech and pharmaceutical researchers, Novogaia aims to expand the fungal chemistry map for therapeutic development.
Founded: 2024
Headquarters: London, England, United Kingdom
Focus: Discovering drug-like natural products from fungi using metabologenomics and machine learning
Stage / Size: Early-stage; reported headcount 1–10
Natural product discovery for therapeutic drug development
2024
Biotechnology Research
| Company |
|---|